Skip to main content

No Infections Seen After Transperineal Biopsy for Prostate Cancer

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 30, 2024.

via HealthDay

MONDAY, Sept. 30, 2024 -- For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrectal biopsy but a significantly lower risk for infection, according to a research letter published online Sept. 19 in JAMA Oncology.

Jim C. Hu, M.D., M.P.H., from the New York Presbyterian Weill Cornell Medicine Hospital in New York City, and colleagues randomly assigned patients with suspicion for prostate cancer to clinic-based transperineal biopsy (without antibiotic prophylaxis) or transrectal biopsy (with targeted prophylaxis). A total of 875 patients were randomly assigned from February 2021 through March 2024; 372 and 370 underwent biopsy in the transperineal and transrectal groups, respectively.

The researchers found no infections in the transperineal group versus six infections in the transrectal group in an intent-to-treat analysis (difference, −1.6 percent). Low and similar rates of other complications were seen. Overall, 55 and 52 percent of patients in the transperineal and transrectal groups, respectively, had high-grade cancer (difference, 2.9 percent).

"Transperineal biopsy significantly lowers the risk of infectious complications versus transrectal biopsy," the authors write. "Transperineal biopsy should be the standard of care for prostate biopsy."

One author disclosed financial ties to Perineologic and KOELIS.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Meal Timing May Shift With Aging, Is Linked to Health Changes

FRIDAY, Sept. 5, 2025 -- Meal timing changes with age and may reflect health changes in older adults, according to a study published online Sept. 4 in Communications...

Industry Payments Common Among Neurologists Prescribing MS Drugs

FRIDAY, Sept. 5, 2025 -- Nearly 80 percent of neurologists prescribing multiple sclerosis (MS) drugs receive payments from industry, according to a study published online Aug. 26...

Housing Assistance Helps Renters With Cancer History

THURSDAY, Sept. 4, 2025 -- Receipt of housing assistance is associated with a lower risk for medical financial hardship among adult renters with a history of cancer, according to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.